Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice

Medical Microbiology and Immunology

Volumn 198, Issue 1, 2009, Pages 5-11

  Wang, Jiu Ling ^a   Qie, Ya Qing ^a   Zhu, Bing Dong ^b   Zhang, Hong Mei ^c   Xu, Ying ^a   Wang, Qing Zhong ^a   Chen, Jia Zhen ^a   Liu, Wei ^a   Wang, Hong Hai ^d  

^a FUDAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c Henan Institute of Medical Sciences   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Ag85B; Mycobacterium tuberculosis; Rv3425; Vaccine

Indexed keywords

ANTIGEN 85B PROTEIN RV3425 FUSION PROTEIN; BACTERIAL DNA; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; INTERFERON PRODUCTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUBERCULOSIS VACCINES;

EID: 58549102083     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-008-0098-x     Document Type: Article

References (28)

1. EM Agger P Andersen 2002 A novel TB vaccine; towards a strategy based on our understanding of BCG failure Vaccine 21 7 14
2. ST Cole R Brosch J Parkhill T Garnier C Churcher D Harris SV Gordon K Eiglmeier S Gas CE Barry III F Tekaia K Badcock D Basham D Brown T Chillingworth R Connor R Davies K Devlin T Feltwell S Gentles N Hamlin S Holroyd T Hornsby K Jagels BG Barrell 1998 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 537 544 10.1038/31159 Medline
3. N Ohara T Yamada 2001 Recombinant BCG vaccines Vaccine 19 4089 4098 10.1016/S0264-410X(01)00155-4 Medline
4. AH Hovav J Mullerad L Davidovitch Y Fishman F Bigi A Cataldi H Bercovier 2003 The Mycobacterium tuberculosis recombinant 27-Kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protectio Infect Immun 71 3146 3154 10.1128/IAI.71.6.3146-3154.2003 Medline
5. D Neeraj R Vivek KT Anil 2003 Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system Immunol Lett 88 175 184 10.1016/S0165-2478(03)00043-9 Medline
6. MA Horwitz 1997 A new TB vaccine Immunologist 5 15 20
7. J Hess SHE Kaufmann 1993 Vaccination strategies against intracellular microbes FEMS Microbiol Immunol 7 95 103 10.1111/j.1574-695X.1993.tb00387.x
8. HG Wiker M Harboe 1992 The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis Microbiol Rev 56 648 661 Medline
9. N Dhar V Rao AK Tyagi 2004 Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis Med Microbiol Immunol 193 19 25 10.1007/s00430-002-0170-x
10. SL Baldwin C D'Souza AD Roberts BP Kelly AA Frank MA Lui JB Ulmer K Huygen DM McMurray IM Orme 1998 Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis Infect Immun 66 2951 2959 Medline
11. MA Horwitz BWE Lee BJ Dillon G Harth 1995 Protective immunity against tuberculosis induced by vaccination with major extracellular proteins against Mycobacterium tuberculosis Proc Natl Acad Sci USA 92 1530 1534 10.1073/pnas.92.5.1530 Medline
12. MA Behr MA Wilson WP Gill H Salamon GK Schoolnik S Rane PM Small 1999 Comparative genomics of BCG vaccines by whole genome DNA microarray Science 284 1520 1523 10.1126/science.284.5419.1520 Medline
13. RK Choudhary S Mukhopadhyay P Chakhaiyar M Sharma KLR Murthy VM Katoch SE Hasnain 2003 PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response Infect Immun 71 6338 6343 10.1128/IAI.71.11.6338-6343.2003 Medline
14. H Zhang J Wang J Lei M Zhang Y Yang Y Chen H Wang 2007 PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients Clin Microbiol Infect 13 2 139 145 10.1111/j.1469-0691. 2006.01561.x Medline
15. MN Norazmi M Mustaffa 2004 Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine Tuberculosis 84 102 109 10.1016/j.tube.2003.08.011 Medline
16. MA Horwitz G Harth BJ Dillon S Maslesa-Galic' 2000 Recombinant bacillus Calmette-Gu'erin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc Natl Acad Sci USA 97 13853 13858 10.1073/pnas.250480397 Medline
17. AS Pym P Brodin L Majlessi R Brosch C Demangel A Williams KE Grifftths G Marchal C Leclerc ST Cole 2003 Recombinant BCG exportiong ESAT-6 confers enhanced protection against tuberculosis Nat Med 9 533 539 10.1038/nm859 Medline
18. U Palendira JM Spratt WJ Britton JA Triccas 2005 Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection Vaccine 23 1680 1685 10.1016/j.vaccine.2004.10.007 Medline
19. CK Stover GP Bansal MS Hanson JE Burlein SR Palaszynski JF Young S Koenig DB Young A Sadziene AG Barbour 1993 Protective immunity elicited by recombinant Bacille Calmette-Guerin(BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine J Exp Med 178 197 209 10.1084/jem.178.1.197 Medline
20. L Bao W Chen HD Zhang XY Wang 2003 Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis Bacillus Calmette-Guérin-tupe strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis Infect Immun 71 1656 1661 10.1128/IAI.71.4.1656-1661. 2003 Medline
21. R Brosch SV Gordon A Pym K Eiglmeier T Garnier ST Cole 2000 Comparative genomics of the mycobacteria Int J Med Microbiol 290 143 152 Medline
22. GG Mahairas PJ Sabo MJ Hickey DC Singh CK Stover 1996 Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis J Bacteriol 178 1274 1282 Medline
23. Y Xu BD Zhu QZ Wang JZ Chen YQ Qie JL Wang HY Wang BL Wang HH Wang 2007 Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-γ confers effective protection against Mycobacterium tuberculosis in C57BL/6mice FEMS Immunol Med Microbiol 51 480 487 10.1111/j.1574-695X.2007.00322.x Medline
24. RJ Howard 1987 Vaccination against malaria: recent advances and the problems of antigenic diversity and other parasite evasion mechanisms Int J Parasitol 17 1 17 29 10.1016/0020-7519(87)90023-3 Medline
25. J Vipond R Vipond E Allen-Vercoe SO Clark GJ Hatch KE Gooch J Bacon T Hampshire H Shuttleworth NP Minton K Blake A Williams PD Marsh 2006 Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge Vaccine 24 6340 6350 10.1016/j.vaccine.2006.05.025 Medline
26. MG Chaitra R Nayak MS Shaila 2007 Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant Vaccine 25 7168 7176 10.1016/j.vaccine.2007. 07.026 Medline
27. A Jurado J Carballido H Griffel HK Hochkeppel GD Wetzel 1989 The immunomodulatory effects of interferon-gamma on mature B lymphocyte responses Experientia 45 521 526 10.1007/BF01990501 Medline
28. RE Tascon E Stavropoulos KV Lukacs MJ Colston 1998 Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon Infect Immun 66 830 834 Medline